A Visual and Comprehensive Review on COVID-19-Associated Pulmonary Aspergillosis (CAPA)
Open Access
- 11 December 2021
- journal article
- review article
- Published by MDPI AG in Journal of Fungi
- Vol. 7 (12), 1067
- https://doi.org/10.3390/jof7121067
Abstract
Coronavirus disease 19 (COVID-19)-associated pulmonary aspergillosis (CAPA) is a severe fungal infection complicating critically ill COVID-19 patients. Numerous retrospective and prospective studies have been performed to get a better grasp on this lethal co-infection. We performed a qualitative review and summarized data from 48 studies in which 7047 patients had been included, of whom 820 had CAPA. The pooled incidence of proven, probable or putative CAPA was 15.1% among 2953 ICU-admitted COVID-19 patients included in 18 prospective studies. Incidences showed great variability due to multiple factors such as discrepancies in the rate and depth of the fungal work-up. The pathophysiology and risk factors for CAPA are ill-defined, but therapy with corticosteroids and anti-interleukin-6 therapy potentially confer the biggest risk. Sampling for mycological work-up using bronchoscopy is the cornerstone for diagnosis, as imaging is often aspecific. CAPA is associated with an increased mortality, but we do not have conclusive data whether therapy contributes to an increased survival in these patients. We conclude our review with a comparison between influenza-associated pulmonary aspergillosis (IAPA) and CAPA.Keywords
Funding Information
- Research Foundation - Flanders (11M6922N)
This publication has 122 references indexed in Scilit:
- Corticosteroids Block Autophagy Protein Recruitment in Aspergillus fumigatus Phagosomes via Targeting Dectin-1/Syk Kinase SignalingThe Journal of Immunology, 2013
- Invasive pulmonary aspergillosis is a frequent complication of critically ill H1N1 patients: a retrospective studyIntensive Care Medicine, 2012
- A Clinical Algorithm to Diagnose Invasive Pulmonary Aspergillosis in Critically Ill PatientsAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Enhancement of anti‐Aspergillus T helper type 1 response by interferon‐β‐conditioned dendritic cellsImmunology, 2010
- IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+regulatory T cellsProceedings of the National Academy of Sciences of the United States of America, 2008
- Galactomannan in Bronchoalveolar Lavage FluidAmerican Journal of Respiratory and Critical Care Medicine, 2008
- Invasive Aspergillosis in the Intensive Care UnitClinical Infectious Diseases, 2007
- Premortem clinical diagnoses and postmortem autopsy findings: discrepancies in critically ill cancer patientsCritical Care, 2007
- Intrapulmonary Pharmacokinetics and Pharmacodynamics of Itraconazole and 14-Hydroxyitraconazole at Steady StateAntimicrobial Agents and Chemotherapy, 2004
- Spectrum of Pulmonary Aspergillosis: Histologic, Clinical, and Radiologic FindingsRadioGraphics, 2001